USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
US and EU Upstream Bioprocessing Growth Opportunities
US and EU Upstream Bioprocessing Growth Opportunities
Increasing Demand for Consumables and Single-use Technologies to Drive Growth in Upstream Bioprocessing
RELEASE DATE
27-Aug-2021
27-Aug-2021
REGION
North America
North America
Research Code: MG3C-01-00-00-00
SKU: HC03445-NA-MT_25726
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
HC03445-NA-MT_25726
Description
The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU upstream bioprocessing market, highlighting drug demand trends, installed capacity developments, market revenue forecast by various segments, competitive landscape, and key growth opportunities that currently exist or are set to develop during the forecast period. The study segments the market by upstream segment of bioprocessing (media preparation systems and consumables and bioreactors—stainless steel and single use) and region (the United States and European Union). Frost & Sullivan delivers the market forecast and breakdown by various segments from 2020 to 2026 in this study, and the key underling factors that are set to influence the growth of the overall market.
Research Highlights
- Biologics drug development pipeline and capacity expansion plans of biologics Contract Development and Manufacturing Organizations (CDMOs) and biopharmaceutical companies
- Installed capacity breakdown by region
- Pros and cons of stainless steel bioreactors and single use bioreactors
- Key acquisitions, investments, and collaborations in the bioprocessing industry
- Facility design considerations and innovations in expression systems
- Growth opportunities centering on single-use technologies, process optimization, and media and supplements
Table of Contents
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top Three Strategic Imperatives on the US and EU Bioprocessing Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Scope of Analysis
Market Segmentation
Key Growth Metrics for the US and EU Upstream Bioprocessing Market
Growth Drivers for the Upstream Bioprocessing Market
Growth Restraints for the Upstream Bioprocessing Market
Key Competitors and Vendor Landscape of Bioprocessing Industry
Biopharmaceutical Industry Overview
Biological Drug Development Pipeline, 2021
Biological Drug Development Pipeline Analysis, 2021
Bio-Contract Development and Manufacturing Organizations (Bio-CDMOs)
Recent Capacity Expansion Plans—Upstream Bioprocessing Market
Forecast Framework—Bio-processing Market
Forecast Methodology—Upstream Bioprocessing Market
Forecast Assumptions and Considerations—Upstream Bioprocessing Market
Quantity Demand Forecast—Mammalian Cell Culture Based Drugs
Quantity Demand Forecast Analysis—Mammalian Cell Culture-based Drugs
Capacity Requirement to Meet Volume Demand Forecast—Mammalian Cell Culture-based Drug Manufacturing
Capacity Requirement to Meet Volume Demand Forecast Analysis—Mammalian Cell Culture-based Drug Manufacturing
Installed Capacity of Biomanufacturing—US and EU
Installed Capacity Analysis of Biomanufacturing—US and EU
Installed Capacity of Biomanufacturing by Region—US and EU
Installed Capacity Analysis of Biomanufacturing by Region—US and EU
Revenue Forecast—Upstream Bioprocessing Market: US and EU
Revenue Forecast—Media Preparation Systems and Consumables Segment: US and EU
Revenue Forecast Analysis—Media Preparation Systems and Consumables Segment: US and EU
Revenue Forecast—Bioreactor Segment: US and EU
Revenue Forecast Analysis—Bioreactor Segment: US and EU
Revenue Forecast—Stainless Steel Bioreactor Systems: US and EU
Revenue Forecast Analysis—Stainless Steel Bioreactor Systems: US and EU
Revenue Forecast—Single-use Bioreactor Systems: US and EU
Revenue Forecast Analysis—Single Use Bioreactor Systems: US and EU
Stainless Steel Bioreactor Systems Versus Single-use Bioreactor Systems
Cost of Manufacturing in Upstream Bioprocessing
Competitive Environment—Upstream Bioprocessing Market
Top Market Participants—Upstream Bioprocessing Market
Some of the Key Acquisitions in the Bioprocessing Industry
Business Models in the Bioprocessing Industry
Key Investments and Collaborations in the Bioprocessing Industry
Design Considerations—Bioprocessing Facilities
Comparative Analysis of Different Facility Types
Emerging and Exciting Innovations in Biomanufacturing
Growth Opportunity 1: Single-use Technology in Manufacturing Standardization of Next-generation Biologics
Growth Opportunity 1: Single-use Technology in Manufacturing Standardization of Next-generation Biologics (continued)
Growth Opportunity 2: Cell Retention Technologies for Process Intensification
Growth Opportunity 2: Cell Retention Technologies for Process Intensification (continued)
Growth Opportunity 3: Innovations in Serum-free Media and Supplements for Boosting Cell Growth
Growth Opportunity 3: Innovations in Serum-free Media and Supplements for Boosting Cell Growth (continued)
Your Next Steps
Why Frost, Why Now?
List of Exhibits
List of Exhibits (continued)
Legal Disclaimer
Popular Topics
The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU upstream bioprocessing market, highlighting drug demand trends, installed capacity developments, market revenue forecast by various segments, competitive landscape, and key growth opportunities that currently exist or are set to develop during the forecast period. The study segments the market by upstream segment of bioprocessing (media preparation systems and consumables and bioreactors—stainless steel and single use) and region (the United States and European Union). Frost & Sullivan delivers the market forecast and breakdown by various segments from 2020 to 2026 in this study, and the key underling factors that are set to influence the growth of the overall market.--BEGIN PROMO--
Research Highlights
- Biologics drug development pipeline and capacity expansion plans of biologics Contract Development and Manufacturing Organizations (CDMOs) and biopharmaceutical companies
- Installed capacity breakdown by region
- Pros and cons of stainless steel bioreactors and single use bioreactors
- Key acquisitions, investments, and collaborations in the bioprocessing industry
- Facility design considerations and innovations in expression systems
- Growth opportunities centering on single-use technologies, process optimization, and media and supplements
| No Index | No |
|---|---|
| Podcast | No |
| Author | Unmesh Lal |
| Industries | Healthcare |
| WIP Number | MG3C-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9600-B1,9571-B1,9568-B1,9611-B1 |
Similar Research
Check items to add to the cart or
